216 related articles for article (PubMed ID: 32280092)
1. Ca:Mg Ratio, APOE Cytosine Modifications, and Cognitive Function: Results from a Randomized Trial.
Zhu X; Borenstein AR; Zheng Y; Zhang W; Seidner DL; Ness R; Murff HJ; Li B; Shrubsole MJ; Yu C; Hou L; Dai Q
J Alzheimers Dis; 2020; 75(1):85-98. PubMed ID: 32280092
[TBL] [Abstract][Full Text] [Related]
2. Magnesium Treatment on Methylation Changes of Transmembrane Serine Protease 2 (TMPRSS2).
Fan L; Zhu X; Zheng Y; Zhang W; Seidner DL; Ness R; Murff HJ; Yu C; Huang X; Shrubsole MJ; Hou L; Dai Q
medRxiv; 2021 Mar; ():. PubMed ID: 33758885
[TBL] [Abstract][Full Text] [Related]
3. Ca:Mg ratio, medium-chain fatty acids, and the gut microbiome.
Fan L; Zhu X; Sun S; Yu C; Huang X; Ness R; Dugan LL; Shu L; Seidner DL; Murff HJ; Fodor AA; Azcarate-Peril MA; Shrubsole MJ; Dai Q
Clin Nutr; 2022 Nov; 41(11):2490-2499. PubMed ID: 36223712
[TBL] [Abstract][Full Text] [Related]
4. Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2).
Fan L; Zhu X; Zheng Y; Zhang W; Seidner DL; Ness R; Murff HJ; Yu C; Huang X; Shrubsole MJ; Hou L; Dai Q
Nutrition; 2021 Sep; 89():111340. PubMed ID: 34116393
[TBL] [Abstract][Full Text] [Related]
5. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
6. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
[TBL] [Abstract][Full Text] [Related]
7. SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment.
Montero-Odasso M; Almeida QJ; Burhan AM; Camicioli R; Doyon J; Fraser S; Li K; Liu-Ambrose T; Middleton L; Muir-Hunter S; McIlroy W; Morais JA; Pieruccini-Faria F; Shoemaker K; Speechley M; Vasudev A; Zou GY; Berryman N; Lussier M; Vanderhaeghe L; Bherer L
BMC Geriatr; 2018 Apr; 18(1):93. PubMed ID: 29661156
[TBL] [Abstract][Full Text] [Related]
8. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
9. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
[TBL] [Abstract][Full Text] [Related]
10. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
[TBL] [Abstract][Full Text] [Related]
11. APOE genotype modifies the association between central arterial stiffening and cognition in older adults.
Cambronero FE; Liu D; Neal JE; Moore EE; Gifford KA; Terry JG; Nair S; Pechman KR; Osborn KE; Hohman TJ; Bell SP; Sweatt JD; Wang TJ; Beckman JA; Carr JJ; Jefferson AL
Neurobiol Aging; 2018 Jul; 67():120-127. PubMed ID: 29656011
[TBL] [Abstract][Full Text] [Related]
12. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation.
Famenini S; Rigali EA; Olivera-Perez HM; Dang J; Chang MT; Halder R; Rao RV; Pellegrini M; Porter V; Bredesen D; Fiala M
FASEB J; 2017 Jan; 31(1):148-160. PubMed ID: 27677546
[TBL] [Abstract][Full Text] [Related]
13. Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort.
Mielke MM; Machulda MM; Hagen CE; Christianson TJ; Roberts RO; Knopman DS; Vemuri P; Lowe VJ; Kremers WK; Jack CR; Petersen RC
Alzheimers Dement; 2016 Mar; 12(3):281-91. PubMed ID: 26602629
[TBL] [Abstract][Full Text] [Related]
14. Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.
Sparks DL; Connor DJ; Sabbagh MN; Petersen RB; Lopez J; Browne P
Acta Neurol Scand Suppl; 2006; 185():3-7. PubMed ID: 16866904
[TBL] [Abstract][Full Text] [Related]
15. The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial.
Park KS; Ganesh AB; Berry NT; Mobley YP; Karper WB; Labban JD; Wahlheim CN; Williams TM; Wideman L; Etnier JL
BMC Neurol; 2020 Jun; 20(1):231. PubMed ID: 32503473
[TBL] [Abstract][Full Text] [Related]
16. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
Suh GH; Jung HY; Lee CU; Oh BH; Lee SK; Lee N; Kim J; Kee BS; Ko D; Kim YH; Ju YS; Hong I; Choi S;
Dement Geriatr Cogn Disord; 2006; 21(1):33-9. PubMed ID: 16254428
[TBL] [Abstract][Full Text] [Related]
17. Cognitive change and the APOE epsilon 4 allele.
Deary IJ; Whiteman MC; Pattie A; Starr JM; Hayward C; Wright AF; Carothers A; Whalley LJ
Nature; 2002 Aug; 418(6901):932. PubMed ID: 12198535
[TBL] [Abstract][Full Text] [Related]
18. Improved cognitive performance following supplementation with a mixed-grain diet in high school students: a randomized controlled trial.
Chung YC; Park CH; Kwon HK; Park YM; Kim YS; Doo JK; Shin DH; Jung ES; Oh MR; Chae SW
Nutrition; 2012 Feb; 28(2):165-72. PubMed ID: 22208555
[TBL] [Abstract][Full Text] [Related]
19. APOE genotype and cognitive change in young, middle-aged, and older adults living in the community.
Bunce D; Bielak AA; Anstey KJ; Cherbuin N; Batterham PJ; Easteal S
J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):379-86. PubMed ID: 23902936
[TBL] [Abstract][Full Text] [Related]
20. Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.
Keenan TD; Agrón E; Mares JA; Clemons TE; van Asten F; Swaroop A; Chew EY;
Alzheimers Dement; 2020 Jun; 16(6):831-842. PubMed ID: 32285590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
